Related Experiment Videos

The effect of intravenous lidocaine on nociceptive processing in diabetic neuropathy

Flemming W Bach1, Troels S Jensen, Jens Kastrup

  • 1Department of Neurology, Gentofte Hospital, CopenhagenDenmark Department of Neurology, Rigshospitalet, CopenhagenDenmark Department of Clinical Physiology, Bispebjerg Hospital, CopenhagenDenmark Department of Clinical Neurophysiology, Gentofte Hospital, CopenhagenDenmark Department of Neurology, Hvidøre Hospital, CopenhagenDenmark.

Pain
|January 1, 1990
PubMed

Insights

Lidocaine effectively relieved pain in patients with diabetic neuropathy by acting on the spinal cord. This intravenous treatment increased pain reflex thresholds, suggesting a localized effect on nerve pathways.

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Diabetic neuropathy is a common complication of diabetes, often causing significant pain.
  • Current treatments for neuropathic pain have limitations, necessitating research into alternative therapies.

Purpose of the Study:

  • To investigate the efficacy and mechanism of action of intravenous lidocaine in treating painful diabetic neuropathy.

Main Methods:

  • A double-blind, controlled study involving 7 patients with painful diabetic neuropathy.
  • Intravenous administration of lidocaine (5 mg/kg) or saline over 30 minutes.
  • Assessment of thermal sensibility, nociceptive flexion reflex thresholds, and Hoffmann reflex.

Main Results:

  • Lidocaine did not alter thermal sensibility.
  • Lidocaine increased nociceptive flexion reflex thresholds in patients and healthy subjects.
  • The effect on reflex thresholds persisted for up to 10 days.
  • Lidocaine did not affect the Hoffmann reflex.

Conclusions:

  • Intravenous lidocaine demonstrates potential for pain relief in diabetic neuropathy.
  • The findings suggest that lidocaine's analgesic effect in this condition is mediated at the spinal cord level.

Related Concept Videos